Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Molecular Diagnostics For Sexually Transmitted Diseases Market show for the 2026–2030 period?

The market size for molecular diagnostics for sexually transmitted diseases has shown rapid expansion in recent years. It is projected to increase from $3.67 billion in 2025 to $4.07 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.7%. The historical growth can be attributed to factors like reliance on conventional serological tests, limited availability of automated pcr systems, low awareness of molecular diagnostics in emerging markets, the growing prevalence of sexually transmitted infections, and manual workflow alongside labor-intensive testing.

The market for molecular diagnostics focused on sexually transmitted diseases is expected to demonstrate significant expansion in the coming years. It is projected to achieve a size of $6.05 billion by 2030, with a compound annual growth rate (CAGR) of 10.4%. This anticipated growth can be attributed to various factors, including technological progress in automated PCR and nucleic acid extraction, the wider implementation of point-of-care molecular diagnostics, improved healthcare infrastructure in developing regions, the increasing embrace of laboratory information management systems (LIMS), and intensified investment in research and development for rapid and multiplexed diagnostic assays. Prominent trends throughout the forecast period involve a growing preference for nucleic acid-based testing methods, the proliferation of point-of-care molecular diagnostic solutions, an escalating requirement for swift and accurate STD detection, the integration of molecular diagnostics with existing laboratory information systems, and the advancement of automated PCR and high-throughput diagnostic platforms.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27351&type=smp

What Drivers Are Shaping The Development Of The Molecular Diagnostics For Sexually Transmitted Diseases Market?

The increasing occurrence of sexually transmitted infections (STIs) is projected to propel the growth of the molecular diagnostics for sexually transmitted diseases market. These infections, caused by bacteria, viruses, or parasites, are transmitted through sexual contact and primarily impact the reproductive and urinary systems. The prevalence of STIs is escalating mainly due to inconsistent use of protection methods, which allows for easier transmission among sexually active individuals. Molecular diagnostics for STIs are crucial in managing these infections by enabling early and accurate detection of pathogens, even in asymptomatic cases, facilitating timely treatment, reducing disease spread, and enhancing overall patient outcomes. For instance, in June 2024, the UK Health Security Agency (UKHSA) stated that England recorded 401,800 new STI diagnoses in 2023, a 4.7% increase from the 383,789 cases reported in 2022. Consequently, the rising prevalence of sexually transmitted infections is fueling the expansion of the molecular diagnostics for sexually transmitted diseases market.

Which Segments Are Contributing To The Growth Of The Molecular Diagnostics For Sexually Transmitted Diseases Market?

The molecular diagnostics for sexually transmitted diseases market covered in this report is segmented –

1) By Product: Instruments And Services, Consumables, Software

2) By Technology: Laboratory Testing, Point-Of-Care Testing

3) By Application: Chlamydia Trachomatis (CT) Or Neisseria Gonorrhoeae (NG) Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus (HSV) Testing, Human Papillomavirus (HPV) Testing, Human Immunodeficiency Virus (HIV) Testing, Trichomonas, Ureaplasma And Mycoplasma, Other Applications

Subsegments:

1) By Instruments And Services: Molecular Diagnostic Analyzers, Automated Polymerase Chain Reaction Systems, Nucleic Acid Extraction Instruments, Diagnostic Service Providers, Maintenance And Calibration Services, Installation And Training Services

2) By Consumables: Deoxyribonucleic Acid Extraction Kits, Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Nucleic Acid Probes, Control And Reference Standards, Detection Enzymes And Buffers

3) By Software: Data Interpretation And Reporting Software, Polymerase Chain Reaction Workflow Management Software, Laboratory Information Management Systems, Diagnostic Decision Support Software, Quality Control Monitoring Software

What Trends Are Reshaping The Dynamics Of The Molecular Diagnostics For Sexually Transmitted Diseases Market?

Leading companies in the molecular diagnostics sector for sexually transmitted diseases are prioritizing the creation of advanced tools, including rapid point-of-care polymerase chain reaction (PCR) devices, to enhance diagnostic speed, precision, and reach. These portable molecular diagnostic instruments integrate sample handling, amplification, and detection within one compact unit, facilitating quick and highly sensitive identification of pathogens beyond conventional lab environments. An illustrative instance is Visby Medical, a US diagnostic technology firm, which introduced the Visby Medical Women’s Sexual Health Test in March 2025. This single-use, handheld PCR device is engineered to detect chlamydia, gonorrhea, and trichomoniasis from vaginal samples in just 30 minutes. It functions independently, requiring no external equipment or cold-chain storage, includes an embedded amplification system, and delivers laboratory-grade results at the point of care, aiding swift clinical choices. Authorized for prescription home use, it marks the first U.S. Food and Drug Administration (FDA)-approved molecular diagnostic test for multiple sexually transmitted infections (STIs) deployable outside clinical environments. Such an introduction signifies a movement towards decentralized diagnostic approaches, thereby boosting accessibility, particularly for populations in remote or underserved areas.

Who Are The Top-Performing Companies In The Molecular Diagnostics For Sexually Transmitted Diseases Market In Recent Years?

Major companies operating in the molecular diagnostics for sexually transmitted diseases market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Illumina Inc., Hologic Inc., bioMérieux S.A., QuidelOrtho Corporation, QIAGEN N.V., Cepheid, Sansure Biotech Inc., OraSure Technologies Inc., Meridian Bioscience, Seegene Inc., Visby Medical Inc., Zeesan Biotech, Binx Health Inc., GCC Biotech, GeneProof, Solone Life Sciences India (P) Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-for-sexually-transmitted-diseases-global-market-report

How Does The Molecular Diagnostics For Sexually Transmitted Diseases Market Perform Across Major Global Regions?

North America was the largest region in the molecular diagnostics for sexually transmitted diseases market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular diagnostics for sexually transmitted diseases market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Molecular Diagnostics For Sexually Transmitted Diseases Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27351&type=smp

Browse Through More Reports Similar to the Global Molecular Diagnostics For Sexually Transmitted Diseases Market 2026, By The Business Research Company

Trade Credit Insurance Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/trade-credit-insurance-global-market-report

Household Insecticides Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/household-insecticides-global-market-report

Household Lending Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/household-lending-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company